The use of postoperative topical mitomycin C in the treatment of recurrent conjunctival papilloma.
To describe the use of postoperative topical mitomycin C (MMC) in the treatment of recurrent conjunctival papilloma. Case report. We report a 26-year-old man with recurrent conjunctival papilloma despite repeated surgical excision, cauterization, and cryotherapy. He was then treated with excision by cryotherapy, followed by a 2-week course of topical MMC eyedrops prescribed at postoperative day 7 (0.02 mg/mL, four times daily). No recurrence was observed 24 months postoperatively, and no complication was observed during the follow-up period. Postoperative topical MMC may be a useful adjunct in the management of recurrent conjunctival papilloma.